HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (115) Citing Articles via Google Scholar Google Scholar Articles by Williams, T. M. Articles by Lisanti, M. P. Search for Related Content PubMed PubMed Citation Articles by Williams, T. M. Articles by Lisanti, M. P.

INVITED REVIEW

Caveolin-1 in oncogenic transformation, cancer, and metastasis

Departments of Molecular Pharmacology and Medicine, and The Albert Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, New York

Caveolae are 50- to 100-nm omega-shaped invaginations of the plasma membrane that function as regulators of signal transduction. Caveolins are a class of oligomeric structural proteins that are both necessary and sufficient for caveolae formation. Interestingly, caveolin-1 has been implicated in the pathogenesis of oncogenic cell transformation, tumorigenesis, and metastasis. Here, we review the available experimental evidence (gleaned from cultured cells, animal models, and human tumor samples) that caveolin-1 (Cav-1) functions as a "tumor and/or metastasis modifier gene." Genetic evidence from the study of Cav-1(–/–) null mice and human breast cancer mutations [CAV-1 (P132L)] supports the idea that caveolin-1 normally functions as a negative regulator of cell transformation and mammary tumorigenesis. In contrast, caveolin-1 may function as a tumor promoter in prostate cancers. We discuss possible molecular mechanisms to explain these intriguing, seemingly opposing, findings. More specifically, caveolin-1 phosphorylation (at Tyr14 and Ser80) and mutations (P132L) may override or inactivate the growth inhibitory activity of the caveolin-scaffolding domain (residues 82–101).

caveolae; cellular signaling; tumor formation; cell invasiveness

This article has been cited by other articles:

				P. Chanvorachote, U. Nimmannit, Y. Lu, S. Talbott, B.-H. Jiang, and Y. Rojanasakul Nitric Oxide Regulates Lung Carcinoma Cell Anoikis through Inhibition of Ubiquitin-Proteasomal Degradation of Caveolin-1 J. Biol. Chem., October 9, 2009; 284(41): 28476 - 28484. [Abstract] [Full Text] [PDF]

				L. Orlichenko, S. G. Weller, H. Cao, E. W. Krueger, M. Awoniyi, G. Beznoussenko, R. Buccione, and M. A. McNiven Caveolae Mediate Growth Factor-induced Disassembly of Adherens Junctions to Support Tumor Cell Dissociation Mol. Biol. Cell, October 1, 2009; 20(19): 4140 - 4152. [Abstract] [Full Text] [PDF]

				A. Cerezo, M. C. Guadamillas, J. G. Goetz, S. Sanchez-Perales, E. Klein, R. K. Assoian, and M. A. del Pozo The Absence of Caveolin-1 Increases Proliferation and Anchorage- Independent Growth by a Rac-Dependent, Erk-Independent Mechanism Mol. Cell. Biol., September 15, 2009; 29(18): 5046 - 5059. [Abstract] [Full Text] [PDF]

				K. A. Sloan, H. A. Marquez, J. Li, Y. Cao, A. Hinds, C. J. O'Hara, S. Kathuria, M. I. Ramirez, M. C. Williams, and H. Kathuria Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines Carcinogenesis, August 1, 2009; 30(8): 1433 - 1442. [Abstract] [Full Text] [PDF]

				Y. Xu, G. Yang, and G. Hu Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation Acta Biochim Biophys Sin, June 1, 2009; 41(6): 488 - 494. [Abstract] [Full Text] [PDF]

				W. A. Messersmith, N.V. Rajeshkumar, A. C. Tan, X. F. Wang, V. Diesl, S. E. Choe, M. Follettie, C. Coughlin, F. Boschelli, E. Garcia-Garcia, et al. Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts Mol. Cancer Ther., June 1, 2009; 8(6): 1484 - 1493. [Abstract] [Full Text] [PDF]

				A. K. Witkiewicz, A. Dasgupta, F. Sotgia, I. Mercier, R. G. Pestell, M. Sabel, C. G. Kleer, J. R. Brody, and M. P. Lisanti An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers Am. J. Pathol., June 1, 2009; 174(6): 2023 - 2034. [Abstract] [Full Text] [PDF]

				P. Palozza, R. Sestito, N. Picci, P. Lanza, G. Monego, and F. O. Ranelletti The sensitivity to {beta}-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells Carcinogenesis, November 1, 2008; 29(11): 2153 - 2161. [Abstract] [Full Text] [PDF]

				B. Joshi, S. S. Strugnell, J. G. Goetz, L. D. Kojic, M. E. Cox, O. L. Griffith, S. K. Chan, S. J. Jones, S.-P. Leung, H. Masoudi, et al. Phosphorylated Caveolin-1 Regulates Rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion Cancer Res., October 15, 2008; 68(20): 8210 - 8220. [Abstract] [Full Text] [PDF]

				K. M. Bailey and J. Liu Caveolin-1 Up-regulation during Epithelial to Mesenchymal Transition Is Mediated by Focal Adhesion Kinase J. Biol. Chem., May 16, 2008; 283(20): 13714 - 13724. [Abstract] [Full Text] [PDF]

				M. F. Ramos, M. W. Lame, H. J. Segall, and D. W. Wilson Smad Signaling in the Rat Model of Monocrotaline Pulmonary Hypertension Toxicol Pathol, February 1, 2008; 36(2): 311 - 320. [Abstract] [Full Text] [PDF]

				C. Bianco, L. Strizzi, M. Mancino, K. Watanabe, M. Gonzales, S. Hamada, A. Raafat, L. Sahlah, C. Chang, F. Sotgia, et al. Regulation of Cripto-1 Signaling and Biological Activity by Caveolin-1 in Mammary Epithelial Cells Am. J. Pathol., February 1, 2008; 172(2): 345 - 357. [Abstract] [Full Text] [PDF]

				P. Lajoie, E. A. Partridge, G. Guay, J. G. Goetz, J. Pawling, A. Lagana, B. Joshi, J. W. Dennis, and I. R. Nabi Plasma membrane domain organization regulates EGFR signaling in tumor cells J. Cell Biol., October 22, 2007; 179(2): 341 - 356. [Abstract] [Full Text] [PDF]

				E. Burgermeister, X. Xing, C. Rocken, M. Juhasz, J. Chen, M. Hiber, K. Mair, M. Shatz, M. Liscovitch, R. M. Schmid, et al. Differential Expression and Function of Caveolin-1 in Human Gastric Cancer Progression Cancer Res., September 15, 2007; 67(18): 8519 - 8526. [Abstract] [Full Text] [PDF]

				N. Odajima, T. Betsuyaku, Y. Nasuhara, and M. Nishimura Loss of Caveolin-1 in Bronchiolization in Lung Fibrosis J. Histochem. Cytochem., September 1, 2007; 55(9): 899 - 909. [Abstract] [Full Text] [PDF]

				K. K. Deeb, A. M. Michalowska, C.-y. Yoon, S. M. Krummey, M. J. Hoenerhoff, C. Kavanaugh, M.-c. Li, F. J. Demayo, I. Linnoila, C.-x. Deng, et al. Identification of an Integrated SV40 T/t-Antigen Cancer Signature in Aggressive Human Breast, Prostate, and Lung Carcinomas with Poor Prognosis Cancer Res., September 1, 2007; 67(17): 8065 - 8080. [Abstract] [Full Text] [PDF]

				D. M. Dudzinski and T. Michel Life history of eNOS: Partners and pathways Cardiovasc Res, July 15, 2007; 75(2): 247 - 260. [Abstract] [Full Text] [PDF]

				S. J. Nixon, A. Carter, J. Wegner, C. Ferguson, M. Floetenmeyer, J. Riches, B. Key, M. Westerfield, and R. G. Parton Caveolin-1 is required for lateral line neuromast and notochord development J. Cell Sci., July 1, 2007; 120(13): 2151 - 2161. [Abstract] [Full Text] [PDF]

				J Bellmunt, L Paz-Ares, M Cuello, F. Cecere, S Albiol, V Guillem, E Gallardo, J Carles, P Mendez, J. de la Cruz, et al. Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy Ann. Onc., March 1, 2007; 18(3): 522 - 528. [Abstract] [Full Text] [PDF]

				H.-I. Kwak, T. Gustafson, R. P. Metz, B. Laffin, P. Schedin, and W. W. Porter Inhibition of breast cancer growth and invasion by single-minded 2s Carcinogenesis, February 1, 2007; 28(2): 259 - 266. [Abstract] [Full Text] [PDF]

				K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al. Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101. [Abstract] [Full Text] [PDF]

				S. S. Siddiqui, Z. K. Siddiqui, S. Uddin, R. D. Minshall, and A. B. Malik p38 MAPK activation coupled to endocytosis is a determinant of endothelial monolayer integrity Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L114 - L124. [Abstract] [Full Text] [PDF]

				F. Sotgia, H. Rui, G. Bonuccelli, I. Mercier, R. G. Pestell, and M. P. Lisanti Caveolin-1, Mammary Stem Cells, and Estrogen-Dependent Breast Cancers. Cancer Res., November 15, 2006; 66(22): 10647 - 10651. [Abstract] [Full Text] [PDF]

				S. Venkatesha, J.-i. Hanai, P. Seth, S. A. Karumanchi, and V. P. Sukhatme Lipocalin 2 Antagonizes the Proangiogenic Action of Ras in Transformed Cells Mol. Cancer Res., November 1, 2006; 4(11): 821 - 829. [Abstract] [Full Text] [PDF]

				J. W. P. Yam, F. C. F. Ko, C.-Y. Chan, D.-Y. Jin, and I. O.-L. Ng Interaction of Deleted in Liver Cancer 1 with Tensin2 in Caveolae and Implications in Tumor Suppression. Cancer Res., September 1, 2006; 66(17): 8367 - 8372. [Abstract] [Full Text] [PDF]

				Y. Chen, M. Dokmanovic, W. D. Stein, R. J. Ardecky, and I. B. Roninson Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells. Cancer Res., September 1, 2006; 66(17): 8749 - 8761. [Abstract] [Full Text] [PDF]

				T. Li, F. Sotgia, M. A. Vuolo, M. Li, W. C. Yang, R. G. Pestell, J. A. Sparano, and M. P. Lisanti Caveolin-1 Mutations in Human Breast Cancer: Functional Association with Estrogen Receptor {alpha}-Positive Status Am. J. Pathol., June 1, 2006; 168(6): 1998 - 2013. [Abstract] [Full Text] [PDF]

				V. A. Torres, J. C. Tapia, D. A. Rodriguez, M. Parraga, P. Lisboa, M. Montoya, L. Leyton, and A. F. G. Quest Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin J. Cell Sci., May 1, 2006; 119(9): 1812 - 1823. [Abstract] [Full Text] [PDF]

				Y. C. Li, M. J. Park, S.-K. Ye, C.-W. Kim, and Y.-N. Kim Elevated Levels of Cholesterol-Rich Lipid Rafts in Cancer Cells Are Correlated with Apoptosis Sensitivity Induced by Cholesterol-Depleting Agents Am. J. Pathol., April 1, 2006; 168(4): 1107 - 1118. [Abstract] [Full Text] [PDF]

				R. C. Mora, V. L. Bonilha, B.-C. Shin, J. Hu, L. Cohen-Gould, D. Bok, and E. Rodriguez-Boulan Bipolar assembly of caveolae in retinal pigment epithelium Am J Physiol Cell Physiol, March 1, 2006; 290(3): C832 - C843. [Abstract] [Full Text] [PDF]

				F. W. Wamunyokoli, T. Bonome, J.-Y. Lee, C. M. Feltmate, W. R. Welch, M. Radonovich, C. Pise-Masison, J. Brady, K. Hao, R. S. Berkowitz, et al. Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance Clin. Cancer Res., February 1, 2006; 12(3): 690 - 700. [Abstract] [Full Text] [PDF]

				A. Tagawa, A. Mezzacasa, A. Hayer, A. Longatti, L. Pelkmans, and A. Helenius Assembly and trafficking of caveolar domains in the cell: caveolae as stable, cargo-triggered, vesicular transporters J. Cell Biol., August 29, 2005; 170(5): 769 - 779. [Abstract] [Full Text] [PDF]